Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection

Journal of the American College of Surgeons

Volumn 186, Issue 3, 1998, Pages 275-283

  Borgstein, Paul J ^a,b   Pijpers, Rik ^b   Comans, Emile F ^b   Van Diest, Paul J ^b   Boom, Rob P ^c   Meijer, Sybren ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c AMSTELLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTISCANNING; TREATMENT PLANNING; TUMOR LOCALIZATION;

AXILLA; BIOPSY; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0031893824     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(98)00011-8     Document Type: Article

References (28)

1. Cady B, Stone MD, Schuler JG, et al. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographie screening. Arch Surg 1996:131:301-308.
2. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: is it indicated? Cancer 1994:73:664-667.
3. Chontos AJ, Maher DP, Ratzer ER, and Fenoglio ME. Axillary lymph node dissection: is it required in T1a breast cancer? J Am Coll Surg 1997:184:493-498.
4. 2 breast cancer at low risk of positive axillary nodes. J Surg Oncol 1997:65:34-39.
5. Deckers PJ. Axillary dissection in breast cancer: when, why, how much, and for how long? Another operation soon to be extinct? [Editorial] J Surg Oncol 1991:48:217-219.
6. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer [Editorial]. Cancer 1994:73:505-508.
7. Pandelidis SM, Peters KL, Walusimbi MS, et al. The role of axillary dissection in mammographically detected carcinoma. J Am Coll Surg 1997:184:341-345.
8. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977:39:456-466.
9. Krag DN, Meijer S, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995:130:654-658.
10. Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg (in press).
11. Krag DN, Weaver DL, Alex JC, and Fairbank JT Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993:2:335-340.
12. Giuliano AE, Kirgan DM, Guenther JM, and Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
13. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996:276:1818-1822.
14. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m colloidal albumin in breast cancer. J Nucl Med 1997:38:366-368.
15. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997:349:1864-1876.
16. Borgstein PJ, Meijer S, and Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349:1668-1669.
17. Bergqvist L, Strand S-E, and Persson BRR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983:13:9-19.
18. Gulec SA, Moffat FL, and Carrol RG. The expanding clinical role for intraoperative gamma probes. In: Freeman LM, ed. Nuclear Medicine Annual. Philadelphia: Lippincott-Raven; 1997: 209-237.
19. McCarthy WH, Thompson JF, and Uren RF. Invited commentary. Arch Surg 1995:130:659.
20. Uren RF, Howman-Giles RB, Thompson JF, et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36:1775-1780.
21. Pijpers R, Collet GJ, Meijer S, and Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995:22:1238-1241.
22. Turner-Warwick RT The lymphatics of the breast. Br J Surg 1953; 46:574-582.
23. 198. Acta Radiol 1955;43: 52-64.
24. Vendrell-Torné E, Setoain-Quinquer J, and Doménech-Torné FM. Study of normal mammary lymphatic drainage using radioactive isotopes. J Nucl Med 1972;13:801-805.
25. McLean RG, and Ege GN. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med 1986; 27: 1116-1124.
26. Ege GN. Lymphoscintigraphy - techniques and applications in the management of breast carcinoma. Semin Nucl Med 1983; 13:26-34.
27. Ege GN, Nold JB, Eng RR, et al. Effects of a metastatic (13762) and nonmetastatic (R3230AC) mammary adenocarcinoma on radiocolloid localization in regional lymph nodes in Fischer 344 rats. J Reticuloendothel Soc 1983;34:449-462.
28. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222:394-401.